Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP2 | O95551 | 1/20 | 0.38 |
| ▸ | NSD2 | O96028 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30039434 | 1.00 | ALDH1A1 (0.44) | ALDH1A1TSHRKMT2AL3MBTL1MEN1 | |
| SCHEMBL2266737 | 0.82 | TRPV4 (0.36) | ALDH1A1TSHRKMT2AL3MBTL1MEN1 | |
| SCHEMBL31453875 | 0.82 | TRPV4 (0.40) | ALDH1A1TSHRKMT2AL3MBTL1MEN1 | |
| SCHEMBL4187153 | 0.80 | TRPV4 (0.35) | ALDH1A1TSHRKMT2AL3MBTL1MEN1 | |
| SCHEMBL27142253 | 0.80 | TRPV4 (0.35) | ALDH1A1TSHRKMT2AL3MBTL1TRPV4 | |
| SCHEMBL4618011 | 0.80 | KMT2A (0.39) | ALDH1A1TSHRKMT2AL3MBTL1MEN1 | |
| SCHEMBL29907244 | 0.80 | TRPV4 (0.35) | ALDH1A1TSHRKMT2AL3MBTL1TRPV4 | |
| SCHEMBL8654400 | 0.80 | ALDH1A1 (0.47) | ALDH1A1TSHRKMT2AL3MBTL1MEN1 | |
| SCHEMBL6208919 | 0.79 | TRPV4 (0.37) | ALDH1A1KMT2AMEN1CYP1A2PKM | |
| SCHEMBL691798 | 0.79 | KMT2A (0.45) | ALDH1A1TSHRKMT2AL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109553754-A | A kind of polyarylsulfone (PAS) modified polyurethane curing agent that high rigidity solvent resistance is good | 韶关市合众化工有限公司 | 2019-04-02 | — | — | CN | claimed |
| CN-107936814-A | The net taste woodcare paint of high hardness polyurethane that a kind of POSS is modified | 合众（佛山）化工有限公司 | 2018-04-20 | — | — | CN | claimed |
| CN-107814936-A | The low free monomer polyurethane curing agent that a kind of POSS is modified | 合众（佛山）化工有限公司 | 2018-03-20 | — | — | CN | claimed |
| CN-107778451-A | A kind of low free high rigidity boron modification polyurethane curing agent | 合众（佛山）化工有限公司 | 2018-03-09 | — | — | CN | claimed |
| EP-2703396-A1 | INHIBITOR OF SODIUM-DEPENDENT GLUCOSE TRANSPORT PROTEIN AND PREPARATION METHOD THEREFOR AND USE THEREOF | Beijing Prelude Pharm. Sci.& Tech. Co., Ltd. (CN) | 2014-03-05 | — | — | EP | claimed |
| US-6593467-B2 | Generating 5'-deoxy-5-fluorouridine; react 2',3'-O-isopropylidene-5- fluorouridine with a sulfonic derivative, hydrolyze, expose to iodine derivative, recover 5'-deoxy-5'-iodo-5-fluorouridine, | CLARIANT FINANCE (BVI) LIMITED (VG) | 2003-07-15 | — | — | US | claimed |
| US-20250296933-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2025-09-25 | — | — | US | disclosed |
| CN-114650852-B | System and method for removing immunosuppressant from biological fluid | 英谬免疫股份有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-117720528-A | Oxadiazole sulfonamide compound containing pyrazole structure, and preparation method and application thereof | 贵州大学 | 2024-03-19 | — | — | CN | disclosed |
| WO-2024007722-A1 | PHARMACEUTICAL COMPOSITION, METHODS OF USE THEREOF FOR TREATING COCAINE ADDICTION, AND NOVEL USE OF HAUSP K444R POINT MUTANT MOUSE | PHARWARD BIOTECHNOLOGY, INC. PTE. LTD. (SG) | 2024-01-11 | — | — | WO | disclosed |
| CN-116718691-A | Method for measuring chromatographic purity of 2,4, 6-trimethylbenzenesulfonyl chloride by utilizing HPLC | 杭州国瑞生物科技有限公司 | 2023-09-08 | — | — | CN | disclosed |
| EP-4204412-A1 | HETEROARYL COMPOUNDS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2023-07-05 | — | — | EP | disclosed |
| CN-115521770-B | High-temperature-resistant thickened oil viscosity-reducing surfactant composition and oil reservoir oil displacement method | 中国石油化工股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-5221796-A | Isoprenoid type phospholipid excellent in biological compatibility, dispersibility and chemical stability | FUJI PHOTO FILM CO., LTD. (JP) | 1993-06-22 | — | — | US | disclosed |
| US-5183910-A | Process and intermediates for chiral epoxides | ELI LILLY AND COMPANY (US) | 1993-02-02 | — | — | US | disclosed |
| US-5097049-A | PROCESS AND INTERMEDIATES FOR CHIRAL EPOXIDES | ELI LILLY AND COMPANY (US) | 1992-03-17 | — | — | US | disclosed |
| EP-0455473-A1 | Process and intermediates for chiral epoxides | ELI LILLY AND COMPANY (US) | 1991-11-06 | — | — | EP | disclosed |
| EP-0375183-A1 | Antiviral dimers and trimers | SCHERING CORPORATION (US) | 1990-06-27 | — | — | EP | disclosed |
| US-4584371-A | Catalytic process for preparing 3-ester-methyl cephalosporins from desacetyl-7-aminocephalosporanic acid | THE UPJOHN COMPANY (US) | 1986-04-22 | — | — | US | disclosed |
| EP-0153874-A2 | Cephalosporin intermediates and their preparation | THE UPJOHN COMPANY (US) | 1985-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296933-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | CYP11B1, CYP11A1, CYP11B2 | ALDH1A1 205/4885TSHR 2982/4885KMT2A 4512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.